Literature DB >> 28680471

Fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy.

S Campbell1, A Clohessy2, C O'Brien3, S Higgins4, M Higgins4, F McAuliffe4.   

Abstract

We present a case report of transient fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy. This reduction in liquor volume resolved following cessation of the medication with no obvious ill-effect on neonatal outcome. The case report is followed by a comprehensive summary of the relevant literature.

Keywords:  Fetomaternal medicine; drugs (medicines); ultrasound

Year:  2017        PMID： 28680471      PMCID： PMC5480648          DOI： 10.1177/1753495X16686466

Source DB:  PubMed          Journal:  Obstet Med        ISSN： 1753-495X


  22 in total

Review 1.  Cyclo-oxygenase (COX) inhibitors for treating preterm labour.

Authors:  J King; V Flenady; S Cole; S Thornton
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

2.  Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions.

Authors:  Laura Cuzzolin; Vassilios Fanos; Bernadette Pinna; Maria di Marzio; Monica Perin; Paola Tramontozzi; Paola Tonetto; Luigi Cataldi
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

Review 3.  Drugs in pregnancy. Rheumatological disorders.

Authors:  M Østensen
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2001-12       Impact factor: 5.237

4.  The effect of short-term indomethacin therapy on amniotic fluid volume.

Authors:  Julie C Sandruck; William A Grobman; Susan E Gerber
Journal:  Am J Obstet Gynecol       Date:  2005-05       Impact factor: 8.661

5.  Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?

Authors:  A Locatelli; P Vergani; P Bellini; N Strobelt; A Ghidini
Journal:  BJOG       Date:  2001-03       Impact factor: 6.531

6.  Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study.

Authors:  K Nezvalová-Henriksen; O Spigset; H Nordeng
Journal:  BJOG       Date:  2013-03-14       Impact factor: 6.531

7.  Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report.

Authors:  O Shen; R Rabinowitz; O Lavie; Y Aboulafia; Y Z Diamant
Journal:  J Perinat Med       Date:  1995       Impact factor: 1.901

8.  Oligohydramnios and fetal renal sonographic appearances related to prostaglandin synthetase inhibitors. A case report.

Authors:  S Fieni; D Gramellini; E Vadora
Journal:  Fetal Diagn Ther       Date:  2004 May-Jun       Impact factor: 2.587

9.  The safety of prolonged indomethacin therapy.

Authors:  Ashlyn H Savage; Brenna L Anderson; Hyagriv N Simhan
Journal:  Am J Perinatol       Date:  2007-04       Impact factor: 1.862

10.  Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors.

Authors:  B Cantor; T Tyler; R M Nelson; G H Stein
Journal:  J Reprod Med       Date:  1980-05       Impact factor: 0.142
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.